Jul 4, 2026 by Geoffrey Seiler3 Stocks to Buy on the AI Infrastructure Sell-OffNvidia, AMD, and Micron look like good buys on this pullback.
Jul 4, 2026 by Reuben Gregg BrewerBerkshire Hathaway's Giant Cash Pile Earns More When Rates Stay High. Here's Why That Matters.Berkshire Hathaway is ready for a market downturn, but its safe pile of cash is increasingly a valuable asset in and of itself.
Jul 4, 2026 by Reuben Gregg BrewerOil is Starting to Flow Out of the Strait of Hormuz Again. Should You Still Buy Oil Stocks?There is one important lesson from the geopolitical conflict in the Middle East: Energy is still vital to the world.
Jul 4, 2026 by Marc GubertiHP vs. Dell: Which AI Infrastructure Stock Is the Better Buy?The two stocks cater to different types of investors, but there's a clear winner for people who want the potential for higher returns.
Jul 4, 2026 by Howard SmithWhy Did Nebius Stock Jump 20% in June?Here's what investors need to know about why Nebius shares soared in June, but did an about-face in July.
Jul 4, 2026 by Reuben Gregg BrewerWhy Ultra-High-Yield UPS Is Investing $48 Million to Control the TemperatureUnited Parcel Service is in the middle of a turnaround, and changing its customer base has been a key part of the process.
Jul 4, 2026 by Thomas NielIs Green Thumb Stock Oversold? The Case for 100% Upside.It's a rare gem among marijuana stocks, for several reasons.
Jul 4, 2026 by Emma NewberyA New Stablecoin Is Taking Aim at Circle's USDC. Here's What Investors Need to Know.Open USD has some big backers, but it still needs to launch its stablecoin.
Jul 4, 2026 by Seena HassounaLadder Capital's Asset Management Head Sells 35,000 Shares — What's Really at Stake?This New York-based REIT specializing in commercial real estate finance reported a significant insider sale in its latest SEC filing.
Jul 4, 2026 by Geoffrey Seiler3 Stocks to Buy on the AI Infrastructure Sell-OffNvidia, AMD, and Micron look like good buys on this pullback.
Jul 4, 2026 by Brendan CoffeyVanguard VCIT vs iShares MUB: Which Bond ETF Should You Choose?Corporate bonds offer higher yields and lower costs, while municipal bonds deliver tax-exempt income with significantly lower volatility.
Jul 4, 2026 by David DierkingPrediction: SPHQ Will Be the Smartest Buy of 2026. Here's Why.With geopolitical, inflation, and AI spending risks growing, investors are already pivoting toward higher-quality stocks in 2026.
Jul 4, 2026 by Brendan CoffeyVanguard VT vs State Street SPDW Global ETF Showdown. Which World-Spanning Fund Is the Better Buy?VT covers some 10,000 stocks worldwide, while SPDW focuses on developed markets ex-US with around 2,000 holdings but a higher yield.
Jul 4, 2026 by Reuben Gregg BrewerBerkshire Hathaway's Giant Cash Pile Earns More When Rates Stay High. Here's Why That Matters.Berkshire Hathaway is ready for a market downturn, but its safe pile of cash is increasingly a valuable asset in and of itself.
Jul 4, 2026 by Matt DiLalloCould This Dividend Stock Help Make You Rich Through Compounding?This REIT has already made early investors rich.
Jul 4, 2026 by Seena HassounaEPR's CFO Sold Shares at a Premium — Here's the Bet Behind the StockThis specialty REIT, focused on experiential real estate, reported a notable insider sale amid a year of double-digit share price gains.
Jul 4, 2026 by Keithen DruryMissed the First Wave of Artificial Intelligence (AI) Stocks? These 2 Aggressive Plays Are Your Second-Chance BuysNebius and CoreWeave are rapidly growing.
Jul 4, 2026 by Alex CarchidiBitcoin ETFs Saw Outflows of $2 Billion in 2 Weeks. Should You Sell?This downtrend is an opportunity for those who are patient.
Jul 4, 2026 by Ryan VanzoI'm Calling It: This Is the Best AI Stock to Buy in the Second Half of 2026This AI stock still trades at a deep discount to its peers.
Jul 4, 2026 by Brendan CoffeyHeartflow vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?Heartflow scales AI diagnostics while Iovance drives personalized cancer therapies, each faces unique financial and operational risks in 2026.
Jul 4, 2026 by Keithen DrurySandisk Stock Was the Biggest Winner in the First Half of 2026. What's Next for the Second Half?Sandisk has dominated the S&P 500 so far this year.
Jul 4, 2026 by Brendan CoffeyDyne Therapeutics vs. Recursion Pharmaceuticals: Which Development Stage Pharma Stock Is a Better Buy in 2026?Targeted therapies meet AI-driven discovery as these biotech innovators reveal sharply contrasting financials, risk factors, and industry partnerships.
Jul 4, 2026 by Erin KennedyVanguard Health Care vs. iShares Biotech: How Do These ETFs Stack Up?Broad healthcare diversification or concentrated biotech growth? Compare cost, risk, and portfolio composition to find your fit.
